Ken Fisher's DAWN Position Overview
Ken Fisher (via Fisher Asset Management, LLC) currently holds 43,698 shares of Day One Biopharmaceuticals, Inc. (DAWN) worth $936,885, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Ken Fisher has maintained a strategic position in DAWN, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2025, adding 186,075 shares. Largest reduction occurred in Q1 2026, reducing 148,125 shares.
Analysis based on 13F filings available since 2013 Q2
Ken Fisher's Day One Biopharmaceuticals (DAWN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Day One Biopharmaceuticals (DAWN) Trades by Ken Fisher
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -148,125 | Reduce 77.22% | 43,698 | $21.44 |
| Q4 2025 | -28,340 | Reduce 12.87% | 191,823 | $9.32 |
| Q3 2025 | -1,820 | Reduce 0.82% | 220,163 | $7.05 |
| Q2 2025 | -53,224 | Reduce 19.34% | 221,983 | $6.50 |
| Q1 2025 | +186,075 | Add 208.76% | 275,207 | $7.93 |
| Q4 2024 | +15,831 | Add 21.60% | 89,132 | $12.67 |
| Q2 2024 | +4,890 | Add 7.15% | 73,301 | $13.78 |
| Q1 2024 | -35 | Reduce 0.05% | 68,411 | $16.52 |
| Q4 2023 | +32,238 | Add 89.04% | 68,446 | $14.60 |
| Q1 2023 | -18 | Reduce 0.05% | 36,208 | $13.37 |
| Q4 2022 | -9,300 | Reduce 20.43% | 36,226 | $21.53 |
| Q3 2022 | +45,526 | New Buy | 45,526 | $20.03 |
Ken Fisher's Day One Biopharmaceuticals Investment FAQs
Ken Fisher first purchased Day One Biopharmaceuticals, Inc. (DAWN) in Q3 2022, acquiring 45,526 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ken Fisher has held Day One Biopharmaceuticals, Inc. (DAWN) for 15 quarters since Q3 2022.
Ken Fisher's largest addition to Day One Biopharmaceuticals, Inc. (DAWN) was in Q1 2025, adding 275,207 shares worth $2.18 M.
According to the latest 13F filing for Q1 2026, Ken Fisher's firm, Fisher Asset Management, LLC, owns 43,698 shares of Day One Biopharmaceuticals, Inc. (DAWN), valued at approximately $936,885.
As of the Q1 2026 filing, Day One Biopharmaceuticals, Inc. (DAWN) represents approximately 0.00% of Ken Fisher's publicly disclosed stock portfolio, making it one of their key holdings.
Ken Fisher's peak holding in Day One Biopharmaceuticals, Inc. (DAWN) was 275,207 shares, as reported at the end of Q1 2025.